VANCOUVER, British Columbia--(BUSINESS WIRE)--ProtoKinetix (OTCBB: PKTX) (www.protokinetix.com) (the “Company” or “ProtoKinetix”) announces that it has terminated and revoked its agreement for the sale of exclusive rights to the AAGPTM Blood Preservative Applications (the “Agreement”) to Intrepid Innovations Corporation (“Intrepid”). The Company delivered a notice of termination and revocation to Intrepid on October 27, 2014, with revocation effective as of October 10, 2014, due to the failure by Intrepid to fulfill its payment obligations to ProtoKinetix under the Agreement.
Entry into the Agreement was previously announced by the Company in a news release dated March 5, 2014.
Help employers find you! Check out all the jobs and post your resume.
